MGRM Directors File Initial Ownership Forms, May 18, 2026

Insider trading filings reveal more than just numbers—they show who believes in a company’s future. Today we examine two director-level filings at MGRM (Monogram Orthopaedics, Inc.), where executives disclosed their initial stock option holdings. These Form 3 filings from directors Gray Colleen and Van Kirk Richard Lee Jr represent standard regulatory disclosures required when insiders take on new roles. Understanding these insider transactions helps investors gauge leadership confidence and board composition changes at the orthopaedic device maker.

Gray Colleen Director Filing and Stock Options

Director Gray Colleen filed an initial ownership disclosure on October 14, 2025, revealing holdings of 3,000 options to acquire common stock at $4.00 per share. This represents a potential value of $12,000 based on the strike price. The SEC filing shows a transaction date of November 30, 2030, indicating these options vest in the future.

Form 3 filings are initial ownership reports required when directors join a company’s board. They establish a baseline of what insiders own at the time they assume their role. Colleen’s option grant reflects standard compensation for board-level participation at MGRM.

Van Kirk Richard Lee Jr Director Disclosure

Director Van Kirk Richard Lee Jr filed his initial ownership report on September 30, 2025, disclosing 2,000 options to acquire common stock at $2.00 per share. This totals approximately $4,000 in potential option value. The filing shows a transaction date of July 31, 2027, suggesting a longer vesting timeline for these securities.

Like Colleen’s filing, this represents a standard Form 3 disclosure required when new directors join the board. The lower strike price compared to Colleen’s options may reflect different grant dates or board compensation structures at MGRM.

What Form 3 Filings Mean for Investors

Form 3 filings are not buy or sell transactions—they are initial ownership disclosures. When directors join a board, they must report all securities they own or have rights to acquire within 10 days. These filings establish transparency and help investors understand leadership stakes in the company.

Both directors’ filings show option-based compensation, which aligns executive interests with shareholder returns. The combined 5,000 options across both directors represent modest but meaningful equity stakes. Meyka AI rates MGRM a grade of B, factoring in leadership structure and financial metrics.

Timing and Future Vesting Considerations

Colleen’s options vest on November 30, 2030, while Van Kirk’s vest on July 31, 2027. These future vesting dates are typical for director compensation packages designed to retain board members long-term. The staggered timelines suggest different appointment dates or compensation cycles.

These Form 3 disclosures provide a snapshot of director equity holdings at MGRM. Investors should monitor future Form 4 filings to track any actual purchases, sales, or option exercises by these board members.

Final Thoughts

Two MGRM directors filed initial ownership disclosures in fall 2025, revealing combined option holdings worth approximately $16,000. Gray Colleen and Van Kirk Richard Lee Jr’s Form 3 filings are routine regulatory requirements that establish baseline equity stakes when joining the board. These filings signal board continuity and standard director compensation practices at the orthopaedic device company. Investors should track future Form 4 filings to monitor actual trading activity by these insiders.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Insider trading data is sourced from public SEC filings. This is not financial advice. Always conduct your own research and consult a licensed financial advisor before making investment decisions.